Market Overview

Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest ROA

Share:
Related UTHR
Benzinga's Top Downgrades
Argus Downgrades United Therapeutics To Hold, Cites 'Challenging Outlook'
Related RDY
Goldman Sachs Sees 8% Upside At Dr. Reddy's
Benzinga's Top Initiations

Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of return on assets.

The trailing-twelve-month return on equity at United Therapeutics (NASDAQ: UTHR) is 15.87%. United Therapeutics' operating margin for the same period is 43.33%.

The trailing-twelve-month return on equity at Warner Chilcott plc (NASDAQ: WCRX) is 11.92%. Warner Chilcott's revenue for the same period is $2.45 billion.

The trailing-twelve-month return on equity at Dr. Reddy's Laboratories (NYSE: RDY) is 9.82%. Dr. Reddy's PEG ratio is 1.29.

The trailing-twelve-month return on equity at Endo Health Solutions (NASDAQ: ENDP) is 8.04%. Endo Health had $340.52 million in total cash for the latest quarter.

Posted-In: Drug Manufacturers-Other Industry Highest ROA mid-cap stocksTrading Ideas

 

Related Articles (ENDP + RDY)

View Comments and Join the Discussion!